Eli Lilly To Pledge $30M To MDR-TB Partnership

Eli Lilly To Pledge $30M To MDR-TB Partnership

Tuesday, October 25, 2011

Pharmaceutical firm Eli Lilly and Co. is expected to announce on Tuesday it "is pledging $30 million to help fight multidrug-resistant tuberculosis [MDR-TB] in developing countries, a disease that kills more than 150,000 people a year," according to the Indianapolis Star. The funds, part of the company's eight-year-old, $165 million Lilly MDR-TB Partnership, will help to�"provide training for nurses, doctors and community volunteers; conduct studies on how to combat the disease; and provide access to medicines," the newspaper notes. The campaign will focus on China, India, Russia and South Africa, "the four countries with the highest burden of MDR-TB, Lilly said," the Indianapolis Star writes (10/25).

The Kaiser Daily Global Health Policy Report is published by the Kaiser Family Foundation. 2011 Henry J. Kaiser Family Foundation. All rights reserved. The report summarizes the latest, most relevant information on U.S. global health policy developments and related news from hundreds of sources. Access today's full report or sign up for an email subscription to the Daily Report.

Source: http://feeds.kff.org/~r/kff/kdghpr/~3/N-G4wpoBN8E/GH-102511-Eli-Lilly-MDRTB.aspx

men\\\'s health forum men\\\'s health magazine subscription healthy foundations health shoulder massage